CRISPR is revolutionizing medicine by enabling precise DNA edits, treating genetic diseases like sickle cell anemia and ...

New research has found a novel target with therapeutic potential for metastatic eye melanoma—an aggressive eye cancer—with ...

CRISPR technology is transforming modern medicine by enabling precise DNA editing to treat genetic disorders, including sickle cell anemia and beta-thalassemia, experts say.

Researchers have made an important step forward toward a long-desired goal: using the gene-editing technology CRISPR to treat cancer. In a study published in Nature, scientists recruited 16 people ...

Benson Hill’s world-class scientists discover new mechanism for CRISPR technology that detects RNA ST. LOUIS--(BUSINESS WIRE)--A groundbreaking research study by a team that included scientists ...

It has been published in Nature Communications. "CRISPR is revolutionary," Wang said. "You can do genome or epigenome editing right in the cell nucleus—so that, essentially, you can treat ...

While we know what CRISPR-Cas systems do for microbes, it’s not clear exactly what Fanzor proteins do in nature. Researchers believe they’re somehow partnered with transposons—maybe helping ...

The new finding shows that exponentially larger amounts of genetic code can be moved or added, potentially increasing CRISPR's functionality. "In nature, transposons have co-opted CRISPR systems ...

Nature has a lot to offer and much of it is likely better than anything we could imagine. To learn more about the work of Kavli Prize Laureates, visit kavliprize.org . To explore more of the ...

In 2023, as Crispr moves into agriculture and climate, we will have the opportunity to radically improve human health in a holistic way that can better safeguard our society and enable millions of ...

Researchers in Lithuania present the molecular structure of a new, more-versatile CRISPR system for gene editing. When you purchase through links on our site, we may earn an affiliate commission ...

The treatment, which will be sold in the US by Vertex Pharmaceuticals, employs CRISPR, the Nobel-winning molecular scissors that have had journalists scrambling for metaphors: “Swiss Army knife ...